Published October 25, 2017
| Published
Patent
Open
Human immunodeficiency virus neutralizing antibodies and methods of use thereof [APPLICATION]
Abstract
The invention provides broadly neutralizing antibodies directed to epitopes of Human Immunodeficiency Virus, or HIV. The invention further provides compositions containing HIV antibodies used for prophylaxis, and methods for diagnosis and treatment of HIV infection.
Additional Information
US Application. Application number US14118496. Priority date 2011-05-17. Filing date 2012-05-17. Publication date 2014-11-06. Government Interests: The research leading to the present invention was supported in part, by National Institutes of Health Grant No. P01 AI08677-01. Accordingly, the U.S. Government has certain rights in this invention.Attached Files
Published - US20140328862A1.pdf
Files
US20140328862A1.pdf
Files
(8.3 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:64c3b4636f8f31d92814264e61b157c2
|
8.3 MB | Preview Download |
Additional details
- Eprint ID
- 82691
- Resolver ID
- CaltechAUTHORS:20171025-163159394
- NIH
- P01 AI08677-01
- Created
-
2017-10-25Created from EPrint's datestamp field
- Updated
-
2019-10-03Created from EPrint's last_modified field